Oxidative/nitrosative stress, autophagy and apoptosis as therapeutic targets of melatonin in idiopathic pulmonary fibrosis

被引:87
|
作者
Hosseinzadeh, Azam [1 ]
Javad-Moosavi, Seyed Ali [2 ]
Reiter, Russel J. [3 ]
Yarahmadi, Rasoul [4 ]
Ghaznavi, Habib [5 ]
Mehrzadi, Saeed [1 ]
机构
[1] Iran Univ Med Sci, Razi Drug Res Ctr, Tehran, Iran
[2] Iran Univ Med Sci, Air Pollut Res Ctr, Tehran, Iran
[3] UT Hlth, Dept Cell & Struct Biol, San Antonio, TX USA
[4] Iran Univ Med Sci, Air Pollut Res Ctr, Dept Occupat Hlth, Tehran, Iran
[5] Zahedan Univ Med Sci, Sch Med, Dept Pharmacol, Zahedan, Iran
关键词
Pulmonary fibrosis; melatonin; oxidative stress; autophagy; apoptosis; EXTRACELLULAR-SUPEROXIDE DISMUTASE; ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; EPITHELIAL-CELLS; LUNG INJURY; DUAL ROLE; TGF-BETA; OXIDASE EXPRESSION; INTRINSIC PATHWAY; NEURAL APOPTOSIS;
D O I
10.1080/14728222.2018.1541318
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease associated with disruption of alveolar epithelial cell layer and expansion of fibroblasts/myofibroblasts. Excessive levels of oxidative/nitrosative stress, induction of apoptosis, and insufficient autophagy may be involved in IPF pathogenesis; hence, the targeting of these pathways may ameliorate IPF. Areas covered: We describe the ameliorative effect of melatonin on IPF. We summarize the research on IPF pathogenesis with a focus on oxidative/nitrosative stress, autophagy and apoptosis pathways and discuss the potential effects of melatonin on these pathways. Expert opinion: Oxidative/nitrosative stress, apoptosis and autophagy could be interesting targets for therapeutic intervention in IPF. Melatonin, as a potent antioxidant, induces the expression of antioxidant enzymes, scavenges free radicals and modulates apoptosis and autophagy pathways. The effect of melatonin in the induction of autophagy could be an important mechanism against fibrotic process in IPF lungs. Further clinical studies are necessary to determine if melatonin could be a candidate for treating IPF.
引用
收藏
页码:1049 / 1061
页数:13
相关论文
共 50 条
  • [31] Therapeutic protocol for idiopathic pulmonary fibrosis
    Bouros, Demosthenes
    Manali, Effrosyni D.
    Papiris, Spyros A.
    Antoniou, Katerina M.
    PNEUMON, 2014, 27 (04) : 285 - 288
  • [32] Therapeutic Update in Idiopathic Pulmonary Fibrosis
    Chan, Andrew L.
    Rafii, Rokhsara
    Louie, Samuel
    Albertson, Timothy E.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2013, 44 (01) : 65 - 74
  • [33] Unraveling the interplay between vital organelle stress and oxidative stress in idiopathic pulmonary fibrosis
    Mohanan, Anushree
    Washimkar, Kaveri R.
    Mugale, Madhav Nilakanth
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2024, 1871 (03):
  • [34] Therapeutic Update in Idiopathic Pulmonary Fibrosis
    Andrew L. Chan
    Rokhsara Rafii
    Samuel Louie
    Timothy E. Albertson
    Clinical Reviews in Allergy & Immunology, 2013, 44 : 65 - 74
  • [35] Autophagy in Idiopathic Pulmonary Fibrosis: Predisposition of the Aging Lung to Fibrosis?
    Zmijewski, Jaroslaw W.
    Thannickal, Victor J.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2023, 68 (01) : 3 - 4
  • [36] Oxygen and pulmonary vasodilation: The role of oxidative and nitrosative stress
    Steinhorn, Robin H.
    Lakshminrusimha, Satyan
    SEMINARS IN FETAL & NEONATAL MEDICINE, 2020, 25 (02):
  • [37] Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin
    Reiter, Russel J.
    Paredes, Sergio D.
    Manchester, Lucien C.
    Tan, Dan-Xian
    CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2009, 44 (04) : 175 - 200
  • [38] Novel drug targets in idiopathic pulmonary fibrosis
    Calvello, Mariarosaria
    Flore, Maria Chiara
    Richeldi, Luca
    EXPERT OPINION ON ORPHAN DRUGS, 2019, 7 (03): : 125 - 146
  • [39] Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis
    Ma, Hongbo
    Wu, Xuyi
    Li, Yi
    Xia, Yong
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [40] Emerging Targets for the Treatment of Idiopathic Pulmonary Fibrosis
    Lucas, Matthew C.
    Budd, David C.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 48, 2013, 48 : 149 - 167